Anticancer Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Jan 2018| TMR069A| Transparency

Report Highlights

Global Anticancer drugs Market: Scope and Research Methodology

This report on the global anticancer drugs market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global anticancer drugs market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global anticancer drugs market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of features of different type of drugs, therapies and cancer types. Additionally, market related factors such as rise in preference of targeted therapies, high prevalence rate of cancer, rise in per capita healthcare expenditure etc. in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Anticancer drugs Market: Segmentation

Cancer is caused due to abnormal growth of the cells. Anticancer drugs are also known as antineoplastic drugs. These drugs prevents and inhibits the growth of cancer cells.

Based on drug types, global anticancer drugs market is segmented into cytotoxic drugs, targeted drugs, and hormonal drugs. The targeted drugs segment is further segmented into monoclonal antibodies, tyrosine kinase inhibitors and others. The segment is anticipated to hold a significant share of the global market. The targeted drugs have a significant demand and is expected to continue dominating the global market throughout the forecast period.

Based on therapy type, global anticancer drugs market is segmented into chemotherapy, targeted therapy, immunotherapy and others. Targeted therapy held the highest share of the market and is anticipated to dominate the market during the forecast period. Side effects of chemotherapy and specificity of the targeted drug are the factors driving the growth of global market.

Based on cancer types, the global anticancer drugs market is segmented into lung cancer, breast cancer, leukemia, colorectal cancer and others. The lung cancer segment is expected to expand at the fast rate due to high prevalence of the disease worldwide.

Anticancer drugs Market: Geographical and Competitive Dynamics

Geographically, the global anticancer drugs market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the anticancer drugs market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include F. Hoffmann-La Roche Ltd, Eli Lilly and Company, CELGENE CORPORATION, Novartis AG, Pfizer Inc, Amgen Inc, Bayer AG, AstraZeneca, Takeda Pharmaceutical Company Limited, Merck & Co., Inc. etc.

The global anticancer drugs market has been segmented as follows:

Global Anticancer drugs Market, by Drug Type

Cytotoxic Drugs
Alkylating Agents
Antimetabolites
Others
Targeted Drugs
Monoclonal Antibodies
Tyrosine Kinase Inhibitors
Others
Hormonal Drugs
Global Anticancer drugs Market, by Therapy Type

Chemotherapy
Targeted Therapy
Immunotherapy
Others
Global Anticancer drugs Market, by Cancer Type

Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Others
Global Anticancer Drugs Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia & NZ
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
South Africa
Rest of MEA

  • Table 1 : Pipeline Analysis, by Phase III
  • Table 2 : Pipeline Analysis, By Phase II and Phase I
  • Table 3 : Pipeline Analysis, By Preclinical Trial (1/2)
  • Table 4 : Pipeline Analysis, By Preclinical Trial (2/2)
  • Table 5 : Global Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 6 : Global Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs, 2015–2025
  • Table 7 : Global Anticancer Drugs Market Value (US$ Mn) Forecast, by Targeted Drugs, 2015–2025
  • Table 8 : Global Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type, 2015–2025
  • Table 9 : Global Anticancer Drugs Market Size (US$ Mn) Forecast, by Therapy Type, 2015–2025
  • Table 10 : Global Anticancer Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 11 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 12 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 13 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type – Targeted Drugs , 2015–2025
  • Table 14 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 15 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 16 : North America Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 17 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 18 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 19 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type – Targeted Drugs , 2015–2025
  • Table 20 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 21 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 22 : Europe Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 23 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 24 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 25 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type – Targeted Drugs , 2015–2025
  • Table 26 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 27 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 28 : Asia Pacific Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 29 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 30 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 31 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type – Targeted Drugs , 2015–2025
  • Table 32 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 33 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 34 : Latin America Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 35 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2015–2025
  • Table 36 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Cytotoxic Drugs,
  • Table 37 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Drug Type – Targeted Drugs , 2015–2025
  • Table 38 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Therapy Type,
  • Table 39 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Cancer Type, 2015–2025
  • Table 40 : Middle East & Africa Anticancer Drugs Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Figure 1 : Global Anticancer Drugs Market, by Drug Type, Market Size (US$ Mn), 2016 (A)
  • Figure 2 : Global Anticancer Drugs Market Revenue (%), by Cancer Therapy, 2016 (A)
  • Figure 3 : Global Anticancer Drugs Market Revenue (%), by Region, 2016 (A)
  • Figure 4 : Opportunity Map, By Drug Type 2016
  • Figure 5 : Opportunity Map, By Therapy type and Cancer Type 2016
  • Figure 6 : Global Anticancer Drugs Market - Key Industry Developments
  • Figure 7 : Global Anticancer Drugs Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 8 : Porter’s Five Forces Analysis
  • Figure 9 : Global Anticancer Drugs Market - Value Chain Analysis
  • Figure 10 : Market Value Share, by Drug Type (2016)
  • Figure 11 : Market Value Share, by Therapy Type (2016)
  • Figure 12 : Market Value Share, by Cancer Types (2016)
  • Figure 13 : Global Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 14 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cytotoxic Drugs, 2015–2025
  • Figure 15 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Targeted Drugs, 2015–2025
  • Figure 16 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hormonal Drugs, 2015–2025
  • Figure 17 : Global Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 18 : Global Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 19 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemotherapy, 2015–2025
  • Figure 20 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Targeted Therapy, 2015–2025
  • Figure 21 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunotherapy, 2015–2025
  • Figure 22 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunotherapy, 2015–2025
  • Figure 23 : Global Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 24 : Global Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 25 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2015–2025
  • Figure 26 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2015–2025
  • Figure 27 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Leukemia, 2015–2025
  • Figure 28 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2015–2025
  • Figure 29 : Global Anticancer Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
  • Figure 30 : Global Anticancer Drugs Market Attractiveness Analysis, by Cancer Type, 2017–2025
  • Figure 31 : Global Scenario of Anticancer Drugs Market
  • Figure 32 : Global Anticancer Drugs Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 33 : Global Anticancer Drugs Market Attractiveness Analysis, by Region
  • Figure 34 : North America Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 35 : North America Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 36 : North America Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 37 : North America Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 38 : North America Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 39 : North America Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 40 : North America Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 41 : North America Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 42 : North America Market Attractiveness Analysis, by Country
  • Figure 43 : Europe Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 44 : Europe Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 45 : Europe Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 46 : Europe Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 47 : Europe Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 48 : Europe Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 49 : Europe Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 50 : Europe Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 51 : Europe Market Attractiveness Analysis, by Country
  • Figure 52 : Asia Pacific Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 53 : Asia Pacific Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 54 : Asia Pacific Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 55 : Asia Pacific Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 56 : Asia Pacific Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 57 : Asia Pacific Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 58 : Asia Pacific Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 59 : Asia Pacific Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 60 : Asia Pacific Market Attractiveness Analysis, by Country
  • Figure 61 : Latin America Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 62 : Latin America Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 63 : Latin America Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 64 : Latin America Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 65 : Latin America Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 66 : Latin America Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 67 : Latin America Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 68 : Latin America Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 69 : Latin America Market Attractiveness Analysis, by Country
  • Figure 70 : Middle East & Africa Anticancer Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 71 : Middle East & Africa Anticancer Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
  • Figure 72 : Middle East & Africa Anticancer Drugs Market Value Share Analysis, by Therapy Type, 2016 and 2025
  • Figure 73 : Middle East & Africa Anticancer Drugs Market Value Share Analysis, by Cancer Type, 2016 and 2025
  • Figure 74 : Middle East & Africa Anticancer Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 75 : Middle East & Africa Anticancer Drugs Market Attractiveness Analysis, by Drug Type
  • Figure 76 : Middle East & Africa Anticancer Drugs Market Attractiveness Analysis, by Therapy Type
  • Figure 77 : Middle East & Africa Anticancer Drugs Market Attractiveness Analysis, by Cancer Type
  • Figure 78 : Middle East & Africa Market Attractiveness Analysis, by Country
  • Figure 79 : Global Anticancer Drugs Market Share Analysis, by Company (2016)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report